CLDI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Calidi Biotherapeutics Inc (CLDI) is not a strong buy at this time for a beginner investor with a long-term strategy. The stock lacks positive financial performance, clear technical signals, or significant catalysts to support a strong upward trend. Given the lack of trading trends, weak financials, and no recent news or influential activity, it is better to hold off on investing in this stock for now.
The MACD is positive but contracting, RSI is neutral at 59.569, and moving averages are converging, indicating no strong trend. The stock is trading near its resistance level (R1: 0.289), and the next resistance (R2: 0.31) is not far above. There is no clear technical signal suggesting a strong buy opportunity.
NULL identified. No recent news, no significant hedge fund or insider activity, and no influential political or congressional trades.
Weak financial performance with declining EPS (-82.30% YoY) and net income (-1.00% YoY). The stock has a forecasted negative trend (-3.16% in the next week and -7.12% in the next month).
The company's financials for Q4 2025 show no revenue growth (0% YoY), a decline in net income to -$4,056,000 (-1.00% YoY), and a significant drop in EPS to -0.57 (-82.30% YoY). Gross margin remains at 0%. Overall, the financials indicate poor performance.
No analyst ratings or price target changes available.
